Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Australia
8 of 45 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Garran, Heidelberg, Melbourne, Murdoch
- Age
- 18 years to 130 years
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Clayton
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - No phaseTaking peopleRadio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
- Where
- Melbourne, Waratah, Westmead, Woolloongabba
- Age
- 18 years and over
- People
- 50
- Run by
- University of Sydney
See details and how to joinNCT05169177 - No phaseTaking peopleLEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Where
- Melbourne, Saint Leonards, Woolloongabba
- Age
- 18 years and over
- People
- 300
- Run by
- University of Sydney
See details and how to joinNCT05184790 - No phaseNot yet taking people in AustraliaThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Melbourne
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 4Taking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Southport
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseNot yet taking people in AustraliaLTFU for All Cell and Gene Therapy Studies
- Where
- East Melbourne
- Age
- 18 years to 130 years
- People
- 64 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06194461 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Parkville
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906